IT1281877B1 - Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici - Google Patents

Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici

Info

Publication number
IT1281877B1
IT1281877B1 IT95PD000090A ITPD950090A IT1281877B1 IT 1281877 B1 IT1281877 B1 IT 1281877B1 IT 95PD000090 A IT95PD000090 A IT 95PD000090A IT PD950090 A ITPD950090 A IT PD950090A IT 1281877 B1 IT1281877 B1 IT 1281877B1
Authority
IT
Italy
Prior art keywords
heavy metal
hyaluronic acid
metal salts
salt
therapeutic agents
Prior art date
Application number
IT95PD000090A
Other languages
English (en)
Inventor
Riaz Khan
Paul Konowicz
Antonella Flaibani
Valentina Gombac
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Publication of ITPD950090A0 publication Critical patent/ITPD950090A0/it
Priority to IT95PD000090A priority Critical patent/IT1281877B1/it
Priority to JP53376996A priority patent/JP4264671B2/ja
Priority to PCT/EP1996/001979 priority patent/WO1996035720A1/en
Priority to EP96916030A priority patent/EP0827514B1/en
Priority to AU58944/96A priority patent/AU695512B2/en
Priority to CA002220682A priority patent/CA2220682C/en
Priority to AT96916030T priority patent/ATE183206T1/de
Priority to DE69603721T priority patent/DE69603721T2/de
Priority to ES96916030T priority patent/ES2137694T3/es
Publication of ITPD950090A1 publication Critical patent/ITPD950090A1/it
Priority to US08/966,636 priority patent/US6017901A/en
Application granted granted Critical
Publication of IT1281877B1 publication Critical patent/IT1281877B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT95PD000090A 1995-05-10 1995-05-10 Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici IT1281877B1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT95PD000090A IT1281877B1 (it) 1995-05-10 1995-05-10 Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
AU58944/96A AU695512B2 (en) 1995-05-10 1996-05-08 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
PCT/EP1996/001979 WO1996035720A1 (en) 1995-05-10 1996-05-08 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
EP96916030A EP0827514B1 (en) 1995-05-10 1996-05-08 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
JP53376996A JP4264671B2 (ja) 1995-05-10 1996-05-08 ヒアルロン酸との又はヒアルロン酸エステルとのコハク酸ヘミエステルの重金属塩類、それらの製造方法及びその医薬組成物
CA002220682A CA2220682C (en) 1995-05-10 1996-05-08 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
AT96916030T ATE183206T1 (de) 1995-05-10 1996-05-08 Schwermetallsalze von bernsteinsäurehalbester mit hyaluronsäure oder hyaluronsäureester, verfahren zu ihrer herstellung und verbundene pharmazeutische zusammensetzungen
DE69603721T DE69603721T2 (de) 1995-05-10 1996-05-08 Schwermetallsalze von bernsteinsäurehalbester mit hyaluronsäure oder hyaluronsäureester, verfahren zu ihrer herstellung und verbundene pharmazeutische zusammensetzungen
ES96916030T ES2137694T3 (es) 1995-05-10 1996-05-08 Sales de metales pesados de los semiesteres del acido succinico con el acido hialuronico, o con los esteres del acido hialuronico. un proceso para la preparacion y composiciones farmaceuticas relacionadas.
US08/966,636 US6017901A (en) 1995-05-10 1997-11-10 Heavy metal salts of succinic acid hemiesters with hyaluronic acid or hyaluronic acid esters, a process for their preparation and relative pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95PD000090A IT1281877B1 (it) 1995-05-10 1995-05-10 Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici

Publications (3)

Publication Number Publication Date
ITPD950090A0 ITPD950090A0 (it) 1995-05-10
ITPD950090A1 ITPD950090A1 (it) 1996-11-10
IT1281877B1 true IT1281877B1 (it) 1998-03-03

Family

ID=11391041

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95PD000090A IT1281877B1 (it) 1995-05-10 1995-05-10 Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici

Country Status (9)

Country Link
EP (1) EP0827514B1 (it)
JP (1) JP4264671B2 (it)
AT (1) ATE183206T1 (it)
AU (1) AU695512B2 (it)
CA (1) CA2220682C (it)
DE (1) DE69603721T2 (it)
ES (1) ES2137694T3 (it)
IT (1) IT1281877B1 (it)
WO (1) WO1996035720A1 (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0781566B1 (en) * 1995-12-26 2004-07-28 Toyo Boseki Kabushiki Kaisha Organic solvent-soluble mucopolysaccharide, antibacterial antithrombogenic composition and medical material
IT1291452B1 (it) 1997-04-14 1999-01-11 Fidia Advanced Biopolymers Srl Rivestimento a base di acido ialuronico e suoi derivati per la protezione di parti elettroniche da agenti esterni
IT1294797B1 (it) * 1997-07-28 1999-04-15 Fidia Advanced Biopolymers Srl Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante
US6872819B1 (en) * 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
ITPD980149A1 (it) 1998-06-17 1999-12-17 Fidia Advanced Biopolymers Srl Protesi tridimensionali comprendenti derivati dell'acido ialuronico per riparare o ricostruire i tessuti danneggiati e processo per la
JP2003089647A (ja) * 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
HK1047884A1 (zh) * 1999-06-18 2003-03-14 Ml Laboratories Plc 生物活性材料
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
AU2003263344B2 (en) 2002-09-11 2009-01-08 Johnson & Johnson Medical Limited Wound dressing materials comprising complexes of anionic polysaccharides with silver
DK200301128A (da) 2003-08-05 2005-02-06 Thomsen Joern Oddershede Tilskudspræparat
US7993678B2 (en) * 2005-09-26 2011-08-09 Novozymes Biopolymer A/S Hyaluronic acid derivatives
IT1402786B1 (it) * 2010-11-19 2013-09-18 Fidia Farmaceutici Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
PT3226905T (pt) 2014-02-27 2022-01-19 Synartro Ab Conjugados de hialuronano com substâncias farmaceuticamente ativas, métodos e composições
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
MA41912A (fr) * 2015-04-07 2018-02-13 Hyalblue S R L Esters de glycosaminoglycane, procédés pour leur préparation et leur utilisation dans des formulations à usage ophtalmique
CZ2015398A3 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
WO2019121488A1 (en) * 2017-12-21 2019-06-27 Nicox S.A. Nitric oxide releasing hyaluronic esters
JP7066909B1 (ja) * 2020-12-25 2022-05-13 参天製薬株式会社 高分子化合物、銀塩およびイオン性等張化剤を含有する水性点眼液
IT202100012737A1 (it) 2021-05-18 2022-11-18 Jointherapeutics S R L Miscele di polisaccaridi e poliamminosaccaridi con proprietà reologiche migliorate
IT202100013787A1 (it) 2021-05-27 2022-11-27 Farmigea Spa Composizione per l’uso nel trattamento di affezioni oculari, quali sindrome dell’occhio secco, specialmente post-chirurgico oftalmico / a composition for use in the treatment of ocular affections, such as dry eye disease, especially after eye surgery
IT202200004613A1 (it) 2022-03-10 2023-09-10 Cmed Aesthetics S R L “procedimento di preparazione di prodotti sterili”
WO2024038087A1 (en) 2022-08-16 2024-02-22 Synartro Ab Method for preparing sterile compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5436388A (en) * 1977-08-26 1979-03-17 Sumitomo Electric Ind Ltd Porous polysaccharide and its preparation
EP0066283B1 (en) * 1981-06-02 1986-09-10 Eupan Corporation Eustatic composition for nonspecifically facilitating and amplifying the generalized homeostatic regulation and maintenance, compensation and repair in living organisms
CA1291034C (en) * 1987-10-19 1991-10-22 Mostafa S. Fahim Composition for promoting epithelial regeneration
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents

Also Published As

Publication number Publication date
JP4264671B2 (ja) 2009-05-20
EP0827514A1 (en) 1998-03-11
ES2137694T3 (es) 1999-12-16
EP0827514B1 (en) 1999-08-11
ATE183206T1 (de) 1999-08-15
DE69603721D1 (de) 1999-09-16
CA2220682A1 (en) 1996-11-14
ITPD950090A0 (it) 1995-05-10
AU5894496A (en) 1996-11-29
AU695512B2 (en) 1998-08-13
DE69603721T2 (de) 2000-01-13
WO1996035720A1 (en) 1996-11-14
JPH11504668A (ja) 1999-04-27
ITPD950090A1 (it) 1996-11-10
CA2220682C (en) 2006-10-24

Similar Documents

Publication Publication Date Title
AU5894496A (en) Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
CH645391A5 (de) Polymere mit succinylobernsteinsaeureester-resten.
DE2602193C2 (de) (1R)-1-(L-Alanylamino)-ethylphosphonsäure und deren pharmakologisch verträgliche Salze, deren Herstellung und Arzneimittel auf der Basis dieser Verbindung bzw. von deren Salzen
RU92016313A (ru) Новые аналоги витамина d, способ их получения, промежуточное соединение, формкомпозиция и способ лечения
RU98100107A (ru) Замещенные липосахариды, используемые для лечения и профилактики эндотоксикоза
DE3570443D1 (en) Oligonucleotides, process for their preparation and their uses as mediators in the enhancement of the effects of interferons
BE901171A (fr) Composition anti-acneique a base de peroxyde de benzoyle et d'au moins un filtre solaire.
HU900218D0 (en) Process for preparation of carboxylic acid- and sulfonic-acid-amides
GB1527152A (en) Transplants
ATE113612T1 (de) Polysulfat eines cyclodextrinderivates und verfahren zu dessen herstellung.
CN108484794A (zh) 一种透明质酸季铵基衍生物及其制备和纯化方法
CA2061309A1 (en) Processes for the preparation of titanylphthalocyanines
EP0133170A3 (en) A compound and a composition for therapeutic or diagnostic use and a method for therapeutic treatment
BE828916A (fr) Procede de traitement anaerobie d'eaux residuaires
GB2291594A (en) Use of cis- or transurocamic acid for the treatment of photodermatoses and immunogenic skin diseases
FR2370110A1 (fr) Procede de traitement de surfaces d'aluminium par oxydation suivie d'une densification
DE450398T1 (de) Komplexe von chrondroitinsulfat mit antientzuendlicher wirkung, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, welche diese enthalten.
KR960017670A (ko) 결정성 세펨 산부가염 및 이의 제조방법
CH245220A (de) Verfahren zur Herstellung eines basischen Esters.
DE102023002817A1 (de) Herstellungsverfahren für Bisethylhexyloxyphenolmethoxphenyltriazin (Bemotrizinol)
ZA918073B (en) Process for the preparation of acylaminomethanephosphonic acids
DE3680964D1 (de) Verfahren zur herstellung von fluorhaltigen diolen und tetrolen.
SU568602A1 (ru) Способ очистки щелочных сточных вод от органических соединений
DE2924566A1 (de) Komplex des dreiwertigen eisens mit chondroitinschwefelsaeure, verfahren zu dessen herstellung und pharmazeutische zusammensetzung
JPS567756A (en) Preparation of optically active d-alpha-methyl-beta- mercaptopropionic acid derivative

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990614